Senate Files

Bills

S. 127 118th Congress

Pharmacy Benefit Manager Transparency Act of 2023

Latest action, Dec 13, 2023: Placed on Senate Legislative Calendar under General Orders. Calendar No. 283.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

14 cosponsors

Sponsored by Maria Cantwell (Democrat). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
4 D · 10 R
  • Democrat
  • Republican
  • Independent
14 senators cosponsoring

Referred to: Senate: Commerce, Science, and Transportation Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

94 clientsQ1 2023Q4 2024

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

AMAC ACTION, INC.
SCHOENING STRATEGIES, LLC
8 reports
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
8 reports
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
8 reports
AMERICAN COLLEGE OF RHEUMATOLOGY
8 reports
AMERICAN MEDICAL ASSOCIATION
8 reports
AMGEN INC
8 reports
AMGEN USA INC.
MARSHALL & POPP, LLC
8 reports
ASSOCIATION FOR CLINICAL ONCOLOGY
8 reports
BIOTECHNOLOGY INNOVATION ORGANIZATION
8 reports
BLUE CROSS AND BLUE SHIELD ASSOCIATION
8 reports
BRISTOL-MYERS SQUIBB
CROSSROADS STRATEGIES, LLC
8 reports
CAMBIA HEALTH SOLUTIONS
8 reports
CENTER FOR FREEDOM AND PROSPERITY
8 reports
CHAMBER OF COMMERCE OF THE U.S.A.
8 reports
CHRONIC CARE POLICY ALLIANCE
8 reports
All 25 of 122 clients
ClientLobbying firmReportsReports totalingFromToSenate
AMAC ACTION, INC.SCHOENING STRATEGIES, LLC8$0Q1 2023Q3 2024yes
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)8$24.8MQ1 2023Q3 2024yes
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION8$5.5MQ1 2023Q3 2024yes
AMERICAN COLLEGE OF RHEUMATOLOGY8$770KQ1 2023Q3 2024yes
AMERICAN MEDICAL ASSOCIATION8$44.9MQ1 2023Q3 2024yes
AMGEN INC8$22.9MQ1 2023Q3 2024yes
AMGEN USA INC.MARSHALL & POPP, LLC8$0Q1 2023Q3 2024yes
ASSOCIATION FOR CLINICAL ONCOLOGY8$1.8MQ1 2023Q3 2024yes
BIOTECHNOLOGY INNOVATION ORGANIZATION8$15.7MQ1 2023Q3 2024yes
BLUE CROSS AND BLUE SHIELD ASSOCIATION8$13.3MQ1 2023Q3 2024yes
BRISTOL-MYERS SQUIBBCROSSROADS STRATEGIES, LLC8$0Q1 2023Q3 2024yes
CAMBIA HEALTH SOLUTIONS8$5.0MQ1 2023Q3 2024yes
CENTER FOR FREEDOM AND PROSPERITY8$0Q1 2023Q3 2024yes
CHAMBER OF COMMERCE OF THE U.S.A.8$142.2MQ1 2023Q3 2024yes
CHRONIC CARE POLICY ALLIANCE8$1.0MQ1 2023Q3 2024yes
COMMUNITY ONCOLOGY ALLIANCE8$2.1MQ1 2023Q3 2024yes
CROHN'S & COLITIS FOUNDATION8$390KQ1 2023Q3 2024yes
ELEVANCE HEALTH, INC.8$13.9MQ1 2023Q3 2024yes
GENENTECH, INC.MARSHALL & POPP, LLC8$0Q1 2023Q3 2024yes
GSK (FKA GLAXOSMITHKLINE INC.)8$9.9MQ1 2023Q3 2024yes
HIGHMARK INC8$1.6MQ1 2023Q3 2024yes
KAISER FOUNDATION HEALTH PLAN INC8$7.6MQ1 2023Q3 2024yes
KROGER CO8$3.1MQ1 2023Q3 2024yes
MERCK & CO., INC.CROSSROADS STRATEGIES, LLC8$0Q1 2023Q3 2024yes
MOLINA HEALTHCARE, INC.8$3.3MQ1 2023Q3 2024yes